Skip to search formSkip to main contentSkip to account menu

elective Progesterone Receptor Modulators [MoA]

Known as: Selective Progesterone Receptor Modulators, Progesterone Agonist/Antagonist, Mixed Progesterone Agonist and Antagonist 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
BackgroundCurrent medical treatments for endometriosis are very limited. Progestin and selective progesterone receptor modulators… 
Review
2017
Review
2017
Leiomyomas, also known as uterine fibroids, are a common benign tumor in women of reproductive age. These lesions disrupt the… 
2015
2015
Endometriosis is an inflammatory estrogen-dependent disease defined by the presence of endometrial glands and stroma at… 
2014
2014
Mifepristone, a progesterone receptor antagonist, was initially discovered in the 1980s and has been licensed for use in medical… 
Review
2013
Review
2013
Uterine leiomyomata are benign, monoclonal tumors arising from smooth muscle cells, which belong to one of the most common… 
Review
2009
Review
2009
We discuss the recently developed hybrid silicon evanescent platform (HSEP), and its application as a promising candidate for… 
Review
2007
Review
2007
Attempts at controlling female fertility through the utilisation of hormonal extracts date back to the beginning of the 20th…